Key Features
» The pharmaceutical industry is under increased pressure to deliver new, effective drugs to end users. High attrition rates, expenditure and the time-consuming nature of the R&D process contribute to the reduced output of approved drugs on the market. With the highest attrition rates existent in the drug discovery and pre-clinical phase it is more important than ever to focus on innovation and strategies to increase output of new drugs on the market.
» As the research and development process can be time-consuming, costly and uncertain it is important to be well informed to avoid potential pitfalls. We provide a platform for organizations to learn, network and exchange ideas. This facilitates affiliations and innovation in the industry to overcome the challenges facing drug discovery and development.
» Pharmaceutical organizations need to find ways to increase the output of new drugs on the market for the benefit of not only the end user but for business survival.
» The Global Discovery and Development Innovation Summit will focus on the multiple facets of drug discovery and development ranging from accelerating the translational process, addressing safety issues early to tackle attrition and new frontiers in biologics and antibodies.
» The GDDIS summit will bring together over 130 senior decision makers in a high networking learning platform to facilitate partnerships and promote innovation.
» Our summit is designed with an interactive and engaging format, where influential leaders from around the world and across all the relevant areas, to learn, debate and network with their peers.
» The summit brings together approximately 120 industry leaders and principle scientists to engage in interactive workshops, panel discussions, and networking sessions to add value in both their key objectives and challenges. GbxSummits has elected 40 of the most influential leaders and forward thinkers in the drug discovery and development realm. The delegation is produced on behalf of GbxSummits and invitations are based on the level of responsibility and experience for both the delegate and speaker. |
|
Key reasons to register:
» Address the attrition rate across drug discovery-key challenges.
» Gain insight into accelerating the translational process: a focus on strategies
» Explore innovation of early preformulation strategies and impact on drug discovery
» Overcome challenges in novel drug targets: therapeutic areas
» Explore the innovation of tools for target validation
» Assess advances in high throughput screening for drug discovery.
» Review Lead optimization: exploring toxicity
» Assess safety issues early to tackle attrition
» Evaluate Biologics and Antibodies: New frontiers
» Identify new approaches and developments in therapeutic areas (Neurology/Oncology)
» Focus on outsourcing the drug discovery process
Specialised Streams:
» Biomarkers, Medicinal Chemistry, Drug Discovery Informatics
Attendee Profile
Drug Discovery, Drug Development, Translational Medicine, Exploratory Medicine, Preformulation, Target Identification & Validation, High throughput screening, Lead optimization, Medicinal chemistry, Drug Discovery Outsourcing, Toxicology, Pre-clinical drug safety, Drug safety, Biomarkers, Personalized Medicine, Drug Discovery Informatics, Data Management
|
